Please use this identifier to cite or link to this item:
Title: FirSt-in-class inhibitor of ribosomal RNA synthesis with antimicrobial activity against staphylococcus aureus
Authors: Yang, X
Luo, MJ
Yeung, ACM
Lewis, PJ
Chan, PKS
Ip, M
Ma, C 
Issue Date: 2017
Publisher: American Chemical Society
Source: Biochemistry, 2017, v. 56, no. 38, p. 5049-5052 How to cite?
Journal: Biochemistry 
Abstract: We report the discovery of the first bacterial ribosomal RNA (rRNA) synthesis inhibitor that has specific antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA). A pharmacophore model was constructed on the basis of the proteinprotein interaction between essential bacterial rlINA transcription factors NusB and NusE and employed for an in silico screen to identify potential leads. One compound, (E)-2-{[(3-ethynylphenyl)imino]methyl}-4-nitrophenol (MC4); demonstrated antimicrobial activity against a panel of S. aureus strains, including MRSA, without significant toxicity to mammalian cells. MC4 resulted in a decrease in the rRNA level in bacteria, and the target specificity of MC4 was confirmed at the molecular level. Results obtained from this work validated the bacterial rRNA transcription machinery as a novel antimicrobial target. This approach may be extended to other factors in rRNA transcription,.. and MC4 could be applied as a chemical probe to dissect the relationship among MRSA infection, MRSA, growth rate, and rRNA synthesis, in addition to its therapeutic potential.
ISSN: 0006-2960
DOI: 10.1021/acs.biochem.7b00349
Appears in Collections:Journal/Magazine Article

View full-text via PolyU eLinks SFX Query
Show full item record


Citations as of May 26, 2018


Citations as of May 27, 2018

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.